A Study Investigating the Effects of Niagen™ in Healthy Adults

---

Sponsor: KGK Science Inc.
Collaborator: ChromaDex, Inc.

Purpose

Evaluate the effect of repeated doses of Niagen™ on Niagen™ metabolite concentrations in blood, urine, and muscle in healthy adults.

Study Design

Double blind, parallel assignment

Dose

100mg/day, 300mg/day, or 1000mg/day

Length of Intervention

8 weeks

Status

Completed

Condition or Disease 

Bioavailability

---

Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.